Redefined indications for subcutaneous mastectomy in patients with benign breast disease.

The indications for subcutaneous mastectomy have been redefined as a result of more recent and more conclusive data. This information has provided us with specific biological markers that define more clearly the high-risk woman for breast cancer. Proliferative disease, with and without atypia, should replace the previous criterion of moderate to severe fibrocystic disease or non-specific mammary dysplasia.